Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A human POC study of CMIO-ONDAN

Trial Profile

A human POC study of CMIO-ONDAN

Phase of Trial: Phase I

Latest Information Update: 06 Feb 2019

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 06 Feb 2019 According to a ChemioCare media release, this study is expected to be conducted in mid-2019.
    • 25 Oct 2018 New trial record
    • 18 Oct 2018 According to a ChemioCare media release, the trial is expected to complete in mid 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top